crystalloid solutions

Subscribe to Selected New Research on crystalloid solutions

1020 relevant articles (58 outcomes, 134 trials/studies) found for this Bio-Agent

Description: refers to RINGER'S LACTATE and SODIUM CHLORIDE soltions used in FLUID THERAPY to rehydrate BLOOD VOLUME

Also Known As:

crystalloid

Relationship Network

Bio-Agent Context: Research Results

Pharmaceutical Preparations

Solutions

Isotonic Solutions: 29

crystalloid solutions: 1020

Experts

1.	Bunn, F: 3 articles (01/2004 - 01/2000)
2.	Roberts, I: 3 articles (01/2004 - 01/2000)
3.	Akpa, E: 3 articles (01/2004 - 01/2000)
4.	Tasker, R: 3 articles (01/2004 - 01/2000)
5.	Dahlgren, G: 2 articles (04/2007 - 09/2005)
6.	Irestedt, L: 2 articles (04/2007 - 09/2005)
7.	Wessel, H: 2 articles (04/2007 - 09/2005)
8.	Granath, F: 2 articles (04/2007 - 09/2005)
9.	Januska, J: 2 articles (06/2004 - 01/2000)
10.	Bashenko, Y: 2 articles (11/2001 - 03/2000)

Related Diseases

1.	Hypotension (Low Blood Pressure) 03/01/1979 - "It was concluded that the abnormal dispersion of solute within the ECF space seen during or after hypotension can be corrected simply by restoring the cardiac output, and that albumin-containing fluid may be more effective in this regard than crystalloid solution alone." 10/01/1994 - "In our series, hypotension responded well to i.v. crystalloid fluid administration. " 04/01/1992 - "This study has demonstrated that rapid administration of crystalloid preload before spinal anaesthesia did not decrease the incidence or severity of hypotension, and questions the role of crystalloid preload." 02/01/1988 - "The high incidence (50-65%) and often profound extent of hypotension seen throughout the trial, confirm the ineffectiveness of crystalloid preload of 1500 ml as a single prophylaxis against hypotension." 04/01/2007 - "The sensitivity and specificity of the stress test for clinically significant hypotension (symptomatic hypotension) for patients randomized to the crystalloid group (n=25) were 69 and 92% respectively. " Order ALL the reference details at left...
2.	Ischemia 05/01/1992 - "In subsequent studies, hearts were subjected to 20 minutes of aerobic perfusion (coronary flow, 2.0 +/- 0.3 ml/min/gm wet weight in blood-perfused hearts versus 11.3 +/- 3.0 ml/min/gm wet weight in crystalloid-perfused hearts; left ventricular developed pressure, 90 +/- 4 and 91 +/- 2 mm Hg, respectively) followed by 30, 45, 60, 75, 90, or 105 minutes of normothermic global ischemia and 40 minutes of reperfusion (n = 4 per group). " 06/01/2005 - "Following hypothermic global ischemia, hearts were crystalloid reperfused in a four-chamber isolated working mode. " 12/01/2003 - "METHODS: Isolated working crystalloid-perfused neonatal rabbit hearts were subjected to 10 min of normothermic ischemia to cause injury before undergoing 4 h of hypothermic (10 degrees C) cardioplegic arrest with a single dose of crystalloid solution (controls, n=21) or with the addition of 0.5 micromol/L HOE (n=24) or 30 micromol/L DMA (n=15). " 01/01/2001 - "METHODS: Isolated and crystalloid-perfused rat hearts underwent 5 cycles of 1 minute of ischemia and 5 minutes of reperfusion (low-grade ischemic preconditioning) or 3 cycles of 5 minutes of ischemia and 5 minutes of reperfusion (high-grade ischemic preconditioning) or time-matched continuous perfusion. " 01/01/2001 - "Langendorff-prepared guinea pig hearts were crystalloid perfused, and the left ventricular (LV) pressure (LVP), first derivative of LVP (LV dP/dt), coronary flow, and O(2) extraction and consumption were measured before, during, and after 30-min global ischemia and 60-min reperfusion. " Order ALL the reference details at left...
3.	Shock 01/01/1991 - "The hypertonic crystalloid solution was effective in the early period of SMAO shock to regain the blood pressure by infusing a small volume. " 01/01/2009 - "Volume replacement therapy is crucial to the treatment of hypovolemic shock, but traditional therapy with crystalloid fluids may not be ideal for these patients." 11/01/2001 - "Comparison of the effects of hypertonic saline and crystalloid infusions on haemodynamic parameters during haemorrhagic shock in dogs." 01/01/1996 - "Hypovolemic shock was effectively managed with polyionic crystalloid solutions. " 11/01/1994 - "Conversely, crystalloid may adversely affect microcirculatory blood flow and resultant O2 supply and use by ischemic tissues in shock. " Order ALL the reference details at left...
4.	Hemorrhage 08/01/2006 - "Given the lack of evidence of benefit for rapid blood volume repletion in acute gastrointestinal haemorrhage, there is need for controlled studies of the most appropriate approach to crystalloid transfusion in acute gastrointestinal bleeding." 06/01/2006 - "The aim of this study was to define how timing of crystalloid administration affects the bleeding patient's hemodynamic response to fluids, using a computer model of blood volume changes during uncontrolled hemorrhage. " 08/01/2006 - "In addition to clear evidence from animal experiments that early restoration of blood volume perpetuates bleeding, there is considerable evidence in humans - both in war and civilian life - that rapid crystalloid infusion is harmful. " 06/01/2006 - "CONCLUSIONS: The timing of crystalloid administration with respect to intrinsic hemostasis shapes the bleeding patient's hemodynamic response. " 06/01/2006 - "A 2-L crystalloid bolus given during ongoing hemorrhage increases blood loss by 4 to 29%, an effect that is inversely related to the initial bleeding rate. " Order ALL the reference details at left...
5.	Wounds and Injuries (Trauma) 01/01/2001 - "INTRODUCTION: To study the volume effect of isotonic and hypertonic crystalloid fluid during ambulance transports after mild trauma, a prospective case-control study was initiated, using the ambulance and helicopter transport system in Stockholm. " 07/01/1989 - "The study demonstrates that a significant drop in hematocrit may be expected in nonbleeding patients who receive crystalloid infusions during trauma evaluation protocols." 01/01/1989 - "When the data from only those studies using trauma patients were pooled, the overall treatment effect showed a 12.3% difference in mortality rate in favor of crystalloid therapy. " 06/01/2007 - "More than ninety percent of surgeons indicate that they routinely take intraperitoneal cultures, do not use intraperitoneal drains, use pure crystalloid to irrigate the abdominal cavity, and perform primary closure of the surgical wound, even in the presence of intraabdominal contamination. " 01/01/2007 - "This trauma case highlights the importance of early hemorrhagic control with balanced crystalloid/transfusion therapy. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Colloids (Colloid)
2.	Dopamine (Intropin)
3.	Sodium Chloride (Saline Solution)
4.	Superoxide Dismutase
5.	Oxygen
6.	Dobutamine
7.	Norepinephrine (Noradrenaline)
8.	Protein C
9.	Diltiazem (Cardizem)
10.	Phenylephrine (Neo-Synephrine)

Related Therapies and Procedures

1.	Resuscitation
2.	Induced Heart Arrest (Cardioplegia)
3.	Spinal Anesthesia
4.	Cardiopulmonary Bypass (Heart-Lung Bypass)
5.	Transplants (Transplant)

Best Treatments:
Research Summary Report
on Hypotension

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 567 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>